Using routine clinical data, the model gauges liver cancer risk better than existing tools, offering a potential way to identify high-risk patients missed by current screening criteria.

In this retrospective cohort study, liver resection (LR) showed higher 1-, 3-, and 5-year survival rates than percutaneous radiofrequency ablation (PRFA) or transarterial chemoembolization (TACE).

Orphan Drug Designation is a key incentive established by the EMA to facilitate the development and authorisation of ...

A machine learning model that analyzes patient demographics, electronic health record data, and routine blood test results ...

Hepatocellular carcinoma (HCC), the most common type of liver cancer and the third-leading cause of cancer-related deaths worldwide, is extremely challenging to treat. However, the future of HCC ...

"Screening is typically recommended for patients with confirmed liver cirrhosis or severe liver disease, since many cases of ...

Patients who are not eligible for surgical resection may or may not be eligible for liver transplant, depending on the extent of their disease, as outlined by the Milan and other criteria above. Some ...

Early-onset HCC incidence is declining, contrasting with rising colorectal cancer rates in young adults. Researchers defined early-onset HCC as occurring under 50 years, impacting future screening ...

A research team affiliated with UNIST has made a significant discovery explaining why liver cancers associated with obesity and metabolic disorders tend to be more aggressive and less responsive to ...